ABclonal Biotechnology, a life science tools and services provider, has raised $92.9 million in Series C financing. Sequoia Capital China and LYFE Capital led the round.
Source: Press Release
ABclonal Biotechnology rakes in $92.9m Series C
ABclonal Biotechnology, a life science tools and services provider, has raised $92.9 million in Series C financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: